Denis Chem Lab Ltd

Wed 2/09/2026,14:59:0 | BSE : DENISCHEM

₹71.450.37 (0.52%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 70.31

Previous Close

₹ 71.08

Volume

7007

Mkt Cap ( ₹ Cr)

₹ 99.15

High

₹ 71.60

Low

₹ 70.31

52 Week High

₹ 103.00

52 Week Low

₹ 56.10

Book Value Per Share

₹ 67.46

Dividend Yield

₹ 3.51

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Denis Chem Lab Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Denis Chem Lab Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Denis Chem Lab has declared 25% Final dividend for the financial year March 2026

    23 Aug 2026, 6:20PM Denis Chem Lab Ltd. on Saturday, 30 May 2026, has announced Final dividend of 25 percent on Equity Share, to its shareholders holding shares on the re

  • Denis Chem Lab - Announcement Under Regulation 30 (LODR) - Notice Of 45Th AGM Along With Annual Report 2025-26

    18 Aug 2026, 4:59PM Notice Of 45th AGM Along With Annual Report 2025-26

  • Denis Chem Lab - Shareholders Meeting - Submission Of Notice Of 45Th AGM Of The Company Along With Annual Report 2025-26

    18 Aug 2026, 4:56PM Submission of Notice of 45th AGM along with Annual Report 2025-26.

  • Denis Chem Lab - Reg. 34 (1) Annual Report.

    18 Aug 2026, 4:50PM We are enclosing herewith Annual Report for FY 2025-26 along with Notice of 45th Annual General Meeting of the members of the Company.

  • Denis Chem Lab - Result-Financials Result For June 30Th, 2026

    13 Aug 2026, 1:59PM The Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th June, 2026. We

  • Denis Chem Lab - Board Meeting Outcome for For Submission Of Unaudited Financial Results For The Quarter Ended On 30Th June,

    13 Aug 2026, 1:47PM The Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th June, 2026. We

  • Denis Chem Lab - Board Meeting Intimation for Taking On Record Unaudited Financial Results For The Quarter Ended On 30Th June

    6 Aug 2026, 12:15PM Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and a

  • Denis Chem Lab - Announcement under Regulation 30 (LODR)-Change in Directorate

    29 Jul 2026, 1:33PM The Board of Directors in their meeting held today reappointed Mr. Himanshu C. Patel as Managing Director of the Company for the period of 3 years wit

  • Denis Chem Lab - Corporate Action-Board to consider Dividend

    29 Jul 2026, 1:27PM Pursuant to regulation 42 of SEBI (LODR), Regulations, The Board of Directors in their meeting held today have fixed Friday, 18th September, 2026 as R

  • Denis Chem Lab - Announcement under Regulation 30 (LODR)-Change in Directorate

    29 Jul 2026, 1:19PM The Board of Directors in their meeting held today have Re-appointed Mr. Himanshu C. Patel as Managing Director of the Company for the period of 3 yea

  • Denis Chem Lab - Announcement under Regulation 30 (LODR)-Change in Management

    29 Jul 2026, 1:14PM Intimation regarding appointment of secretarial Auditor of the Company for the term of 5 year subject to approval of shareholders/ Members in ensuing

  • Denis Chem Lab - Shareholder Meeting - 45Th Annual General Meeting On 25Th September, 2026

    29 Jul 2026, 1:10PM The Board of Directors of the Company in their meeting held today decided the date of Board Meeting, Record date for Dividend, E-voting for AGM and ot

  • Denis Chem Lab - Board Meeting Outcome for Outcome Of Board Meeting - Intimation Of Date Of Annual General Meeting, E-Voting

    29 Jul 2026, 1:06PM The Board of Directors in their Meeting held today has decided Date of Annual General Meeting, record date for Dividend, Evoting for AGM and other mat

  • Denis Chem Lab has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    16 Jul 2026, 9:00PM As of June 2026, 38.98% is owned by Indian Promoters and 61.02% by Public. <p align=justify> Top three Promoters holding highest number of shares of D

  • Denis Chem Lab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2026, 6:26PM We are herewith submitting the Certificate issued by MUFG Intime India Private Limited, RTA of the Company for the Quarter ended on 30th June, 2026
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Denis Chem Lab Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 95.7578 85.9246 81.4125 74.1967 69.6689
Liabilities 95.7578 85.9246 81.4125 74.1967 69.6689
Equity 13.8767 13.8767 13.8767 13.8767 13.8767
Gross Profit 17.648 16.1083 21.2332 18.7799 14.3514
Net Profit 8.4093 8.0758 11.1558 7.8598 6.263
Cash From Operating Activities 4.1317 12.0919 17.6035 16.3396 17.0703
NPM(%) 4.62 4.66 6.64 4.88 4.58
Revenue 181.7204 173.2997 167.822 160.8489 136.5565
Expenses 164.0724 157.1914 146.5888 142.069 122.2051
ROE(%) 8.98 8.62 11.91 8.39 6.68

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Denis Chem Lab Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 874.00 0.44 22.10 40.57 -26.19 0.57
Lotus Eye Hospital and Institute Ltd 106.25 -2.52 1542.86 147.82 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.67 0.51 0.00 306.92 -39.50 0.00
Astec Lifesciences Ltd 572.25 1.05 0.00 158.38 -363.14 0.00

Company Info

The Company is Public Limited Pharmaceutical Company incorporated in 1982. Company started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years Company have been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. Company Manufacture and market sterile Intravenous injectibles in Both Glass and Plastic Bottles with capacity of 810 million bottles per Annum. 1980 -Incorporated as a Private Limited Company on July 15, 1980 1982 -Conversion into Public Limited Company -Initial Public Offer of our Company 1984 -Rights Issue of 70,000 equity shares at a issue price of ` 10/- per share 1989 -Rights Issue of 1,17,728 equity shares at a issue price of ` 10/- per share 1991 -Production capacity increased to 8 million glass bottles per annum 1994 -Production capacity again increased to 20 million glass bottles for I.V. Fluids 1995 -Further Public Offer of 1,80,750 equity shares 2006 -Company forayed into manufacturing of IV fluids in PP bottles using BFS technology 2013 -Issue of Bonus Shares in the ratio of 1:1 2014 -Listing of Equity Shares of our Company on BSE Limited under the Direct Listing Norms -Sucessfuly Launched Aqua Pulse Pan India -Company has issues Rights in the Ratio of 2 : 1 2018 -21,34,872 Equity Shares of Rs. 10/- each at a premium of Rs. 74/- per share on 'Rights Basis'

The Company is Public Limited Pharmaceutical Company incorporated in 1982. Company started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years Company have been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. Company Manufacture and market sterile Intravenous injectibles in Both Glass and Plastic Bottles with capacity of 810 million bottles per Annum. 1980 -Incorporated as a Private Limited Company on July 15, 1980 1982 -Conversion into Public Limited Company -Initial Public Offer of our Company 1984 -Rights Issue of 70,000 equity shares at a issue price of ` 10/- per share 1989 -Rights Issue of 1,17,728 equity shares at a issue price of ` 10/- per share 1991 -Production capacity increased to 8 million glass bottles per annum 1994 -Production capacity again increased to 20 million glass bottles for I.V. Fluids 1995 -Further Public Offer of 1,80,750 equity shares 2006 -Company forayed into manufacturing of IV fluids in PP bottles using BFS technology 2013 -Issue of Bonus Shares in the ratio of 1:1 2014 -Listing of Equity Shares of our Company on BSE Limited under the Direct Listing Norms -Sucessfuly Launched Aqua Pulse Pan India -Company has issues Rights in the Ratio of 2 : 1 2018 -21,34,872 Equity Shares of Rs. 10/- each at a premium of Rs. 74/- per share on 'Rights Basis'

Parent Organisation

Denis Chem Lab Ltd.

Founded

15/07/1980

Managing Director

Dr.Himanshu Patel

NSE Symbol

FAQ